Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 6/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL1952726 | 0.98 | TSHR (0.47) | CHRM5CHRM1CHRM3MAPTBLM | |
| SCHEMBL28171146 | 0.93 | TSHR (0.46) | CHRM5CHRM1CHRM3MAPTBLM | |
| SCHEMBL8516636 | 0.93 | TSHR (0.46) | CHRM5CHRM1CHRM3MAPTBLM | |
| Sulfuric Acid SCHEMBL1952728 | 0.93 | TSHR (0.46) | CHRM5CHRM1CHRM3MAPTBLM | |
| Hydrochloric Acid SCHEMBL27659543 | 0.92 | CHRM5 (0.44) | CHRM5CHRM1CHRM3MAPTBLM | |
| Sulfuric Acid SCHEMBL27725119 | 0.92 | TSHR (0.44) | CHRM5CHRM1CHRM3MAPTBLM | |
| Sulfuric Acid SCHEMBL1706603 | 0.91 | CHRM5 (0.50) | CHRM5CHRM1CHRM3MAPTBLM | |
| Hydrochloric Acid SCHEMBL134541 | 0.91 | CHRM5 (0.57) | CHRM5CHRM1CHRM3MAPTBLM | |
| Sulfuric Acid SCHEMBL27994079 | 0.90 | TSHR (0.46) | CHRM5CHRM1CHRM3MAPTBLM | |
| SCHEMBL304033 | 0.90 | TSHR (0.43) | CHRM5CHRM1CHRM3MAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618000-B2 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260071533-A1 | TREATMENT FLUID SELECTION | HALLIBURTON ENERGY SERVICES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-12247165-B2 | Anti-syneresis agents for fracturing operations | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-03-11 | — | — | US | disclosed |
| US-20250075122-A1 | ADDITIVES TO PREVENT THERMAL THINNING IN POLYMER GEL SYSTEMS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20250051634-A1 | ANTI-SYNERESIS AGENTS FOR FRACTURING OPERATIONS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-02-13 | — | — | US | disclosed |
| US-20250051635-A1 | FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-02-13 | — | — | US | disclosed |
| WO-2025006003-A1 | FRICTION REDUCTION OF ACIDIC TREATMENT FLUIDS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| US-12139667-B1 | Friction reduction of acidic treatment fluids | HALLIBURTON ENERGY SERVICES, INC. (US) | 2024-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071533-A1 | TREATMENT FLUID SELECTION | PLG, SOST, CSTB | CHRM5 3070/4885CHRM1 2745/4885CHRM3 2160/4885 |
| US-12618000-B2 | Friction reduction of acidic treatment fluids | GFER, FGB, NSF | CHRM5 4511/4885CHRM1 4594/4885CHRM3 3910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.